Technical Analysis for MYMX - Mymetics Corp

Grade Last Price % Change Price Change
grade D 0.033 -12.93% -0.0049
MYMX closed down 12.93 percent on Friday, January 24, 2020, on 1.52 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical MYMX trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Crossed Above 200 DMA Bullish -12.93%
Crossed Above 20 DMA Bullish -12.93%
Crossed Above 50 DMA Bullish -12.93%
180 Bullish Setup Bullish Swing Setup -12.93%
Below Lower BB Weakness 3.13%
Lower Bollinger Band Touch Weakness 3.13%
Older signals for MYMX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Mymetics Corporation is a vaccine company. The Company is focused on developing vaccines for infectious diseases. The Company has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Its prophylactic HIV-1 vaccine candidate is constituted of virosomes linked to conserved antigens derived from the HIV-1 glycoprotein 41 (gp41) proteins from the clade B. The RSV vaccine consists of the reconstituted membrane of RSV containing the native viral proteins. The HSV vaccine candidate consists of the reconstituted membrane of HSV-1 or HSV-2. The intranasal influenza vaccine includes the reconstituted membrane of influenza virus.
Medicine Medical Specialties RTT Branches Of Biology Infectious Diseases Vaccines Influenza Vaccination Hiv/Aids Malaria Sexually Transmitted Diseases And Infections Aids Immune Deficiency Syndrome Influenza Virus

Is MYMX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.0599
52 Week Low 0.02
Average Volume 53,901
200-Day Moving Average 0.0372
50-Day Moving Average 0.0369
20-Day Moving Average 0.0365
10-Day Moving Average 0.0355
Average True Range 0.0046
ADX 34.0
+DI 11.3885
-DI 28.3931
Chandelier Exit (Long, 3 ATRs ) 0.0262
Chandelier Exit (Short, 3 ATRs ) 0.0378
Upper Bollinger Band 0.0415
Lower Bollinger Band 0.0315
Percent B (%b) 0.15
BandWidth 27.3973
MACD Line -0.0008
MACD Signal Line -0.0005
MACD Histogram -0.0003
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0404
Resistance 3 (R3) 0.0412 0.0395 0.0391
Resistance 2 (R2) 0.0395 0.0377 0.0391 0.0387
Resistance 1 (R1) 0.0363 0.0365 0.0355 0.0355 0.0383
Pivot Point 0.0346 0.0346 0.0342 0.0342 0.0346
Support 1 (S1) 0.0314 0.0328 0.0306 0.0306 0.0277
Support 2 (S2) 0.0297 0.0316 0.0293 0.0273
Support 3 (S3) 0.0265 0.0297 0.0269
Support 4 (S4) 0.0257